Efficacy and safety of sofosbuvir based therapy in patients with chronic hepatitis C virus infection and malignancies: A prospective, observational study
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir; Ribavirin; Simeprevir; Velpatasvir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 08 Nov 2018 Results published in the American Journal of Gastroenterology
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 06 Jun 2017 New trial record